These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12836404)

  • 21. Video podcast: Adoptive immunotherapy for cancer.
    Stadanlick J
    Immunol Rev; 2014 Jan; 257(1):6. PubMed ID: 24329785
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application.
    Gomes AQ; Martins DS; Silva-Santos B
    Cancer Res; 2010 Dec; 70(24):10024-7. PubMed ID: 21159627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic cell-derived exosomes for cancer immunotherapy: what's next?
    Viaud S; Théry C; Ploix S; Tursz T; Lapierre V; Lantz O; Zitvogel L; Chaput N
    Cancer Res; 2010 Feb; 70(4):1281-5. PubMed ID: 20145139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunotherapy of tumors: from the first experimental studies to the recent clinical applications. I. Passive immunotherapy].
    Burrai I; Di Lallo A
    Minerva Med; 1991 Sep; 82(9):519-28. PubMed ID: 1944999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
    Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
    Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The promise of T-lymphocyte immunotherapy for the treatment of malignant disease.
    Thomas AK; June CH
    Cancer J; 2001; 7 Suppl 2():S67-75. PubMed ID: 11777267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular therapy to control tumor progression.
    Kapp M; Rasche L; Einsele H; Grigoleit GU
    Curr Opin Hematol; 2009 Nov; 16(6):437-43. PubMed ID: 19587587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the stroma by T cells to limit tumor growth.
    Zhang B
    Cancer Res; 2008 Dec; 68(23):9570-3. PubMed ID: 19047130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Fry TJ; Lankester AC
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):109-27. PubMed ID: 20113898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current status of immunotherapy in oncology].
    Zielinski C
    Acta Med Austriaca; 1991; 18(1):20-4. PubMed ID: 1713730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive T-cell immunotherapy of cancer.
    Li Q; Chang AE
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):105-17. PubMed ID: 10515683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adoptive cellular therapy.
    Urba WJ; Longo DL
    Cancer Chemother Biol Response Modif; 1990; 11():265-80. PubMed ID: 2223395
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetically engineered T cells as adoptive immunotherapy of cancer.
    Ma Q; Gonzalo-Daganzo RM; Junghans RP
    Cancer Chemother Biol Response Modif; 2002; 20():315-41. PubMed ID: 12703212
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic redirection of T cells for cancer therapy.
    Westwood JA; Kershaw MH
    J Leukoc Biol; 2010 May; 87(5):791-803. PubMed ID: 20179152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer cells and tumor control.
    Cooley S; Weisdorf DS
    Curr Opin Hematol; 2010 Nov; 17(6):514-21. PubMed ID: 20827184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular immunotherapy with dendritic cells in cancer: current status.
    Nencioni A; Brossart P
    Stem Cells; 2004; 22(4):501-13. PubMed ID: 15277696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy and the development of cancer vaccines.
    Dalgleish AG
    Expert Rev Vaccines; 2006 Feb; 5(1):1-4. PubMed ID: 16451100
    [No Abstract]   [Full Text] [Related]  

  • 38. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor reactive T cells get a boost.
    Pardoll DM
    Nat Biotechnol; 2002 Dec; 20(12):1207-8. PubMed ID: 12454671
    [No Abstract]   [Full Text] [Related]  

  • 40. Adoptive cellular immunotherapy of cancer: a three-signal paradigm for translating recent developments into improved treatment strategies.
    Jensen SM; Fox BA
    Cancer Treat Res; 2005; 123():293-336. PubMed ID: 16211876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.